Acute Myocardial InfarctionNCT04572061
Emergency Coronary Artery Bypass Graft in Acute Myocardial Infarction
An observational study of Acute Myocardial Infarction, run by Saud Al Babtain Cardiac Center at 1 site in Saudi Arabia.
Trial summary
A retrospective study investigating the early outcome of emergency CABG post MI in patients who were operated at Saud Al Babtain Cardiac Center. Read more about this study
- Who is it for?
- Ages 17 years and older
- Conditions the study is for
- Acute Myocardial Infarction
- How many people
- 109 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 7 Feb 2017to 31 Jul 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All adult patients admitted at Saud Al Babtain Cardiac Center with post cardiogenic shock who underwent CABG.
Who may be able to join
- Patients with post cardiogenic shock who underwent CABG
- =/> 17 years old
Who cannot join
- Patients other than post cardiogenic shock who underwent CABG or any cardiac surgeries
- <17 years old
Trial locations and contacts
1 site in 1 country.
About this study
A retrospective study investigating the early outcome of emergency CABG post MI in patients who were operated at Saud Al Babtain Cardiac Center.
Read the detailed description
A retrospective study of surgical patients who underwent Coronary Artery Bypass Graft for Acute Myocardial Infarction between December 2013 and February 2018 determining outcomes on morbidity and mortality.
- Conditions
- Acute Myocardial Infarction
- Keywords
- CABG
What is being measured
The primary outcome is the main question the study is designed to answer.
STEMI and Emergency CABG
Evaluate patients the early outcome of emergency CABG post MI.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Oct 2020
- Study start7 Feb 2017
- Primary completion31 Oct 2017
- Study completion31 Jul 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 109 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saud Al Babtain Cardiac Center
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Ahmed Attiea, MD, Principal investigator, Saud Al Babtain Cardiac Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04572061
- Sponsor's protocol ID
- SBCC-2017-04
- Status last verified
- Sep 2020
- First submitted
- 14 Jun 2020
- Last updated
- 1 Oct 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Emergency Coronary Artery Bypass Graft in Acute Myocardial Infarction
- ClinicalTrials.gov ID
- NCT04572061
- Acronym / sponsor ID
- SBCC-2017-04
- Conditions
- Acute Myocardial Infarction
- Keywords
- CABG
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 109 participants (actual)
- Lead sponsor
- Saud Al Babtain Cardiac CenterOther government
- Study start
- 7 Feb 2017 (actual)
- Primary completion
- 31 Oct 2017 (actual)
- Study completion
- 31 Jul 2018 (actual)
- First posted
- 1 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A retrospective study investigating the early outcome of emergency CABG post MI in patients who were operated at Saud Al Babtain Cardiac Center.
Detailed description
A retrospective study of surgical patients who underwent Coronary Artery Bypass Graft for Acute Myocardial Infarction between December 2013 and February 2018 determining outcomes on morbidity and mortality.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 17 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All adult patients admitted at Saud Al Babtain Cardiac Center with post cardiogenic shock who underwent CABG.
Key inclusion criteria (2 listed)
- Patients with post cardiogenic shock who underwent CABG
- =/> 17 years old
Key exclusion criteria (2 listed)
- Patients other than post cardiogenic shock who underwent CABG or any cardiac surgeries
- <17 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
STEMI and Emergency CABG
Time frame: 1 year
Evaluate patients the early outcome of emergency CABG post MI.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Acute Myocardial Infarction
Not yet recruitingObservational study
Elicit Drugs in Myocardial Infarction
Young Patients With Acute Myocardial Infarction
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients
Myocardial Infarction, Myocarditis Acute
Enrolling by invitationPhase 3
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Acute Myocardial Infarction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ahmed Attiea, MD principal investigator
Saud Al Babtain Cardiac Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Myocardial Infarction, run by Saud Al Babtain Cardiac Center at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
STEMI and Emergency CABG (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2020.